Related Experiment Video
Updated: Dec 18, 2025

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
[HELLP Syndrome: clinical-analytical characteristics and evolution observed in two years of experience]
A M Ghelfi1, F Garavelli1, F A Passarino2
1Servicio de Clínica Médica, Hospital Escuela Eva Perón, Santa Fe, Argentina.
Insights
HELLP syndrome, a severe form of preeclampsia, often presents variably, predominantly in gestational hypertension cases. While maternal complications were common, this study found no maternal deaths.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care Medicine
Background:
- HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) is a severe variant of preeclampsia.
- The syndrome exhibits diverse clinical presentations, including complete/incomplete forms, varying severity classes, and antepartum/postpartum onset.
- Understanding HELLP syndrome's characteristics is crucial for managing hypertensive disorders in pregnancy.
Purpose of the Study:
- To describe and analyze the characteristics and clinical evolution of HELLP syndrome in hypertensive pregnant patients.
- To identify common presentations and complications associated with HELLP syndrome.
- To evaluate maternal outcomes in a cohort of patients with HELLP syndrome.
Main Methods:
- Retrospective cohort study over two years.
- Inclusion of hypertensive pregnant women diagnosed with HELLP syndrome during hospitalization.
- Analysis of demographic data, clinical characteristics, syndrome classification, and maternal outcomes.
Main Results:
- The study included 318 hypertensive pregnant women, with 28 diagnosed with HELLP syndrome.
- The average maternal age was 25.8 years, and gestational age at diagnosis was 31 weeks.
- HELLP syndrome was predominantly gestational (24/28), antepartum (25/28), and early onset (18/25), with incomplete forms and Class II thrombocytopenia being most frequent. 17 patients required intensive care, and 10 developed complications, but no maternal deaths occurred.
Conclusions:
- HELLP syndrome presentation is variable, frequently observed in gestational hypertension, antepartum, and early onset.
- Incomplete forms and Class II thrombocytopenia are more common presentations.
- Despite frequent maternal complications, HELLP syndrome management in this cohort resulted in no maternal mortality.
Introduction:
HELLP syndrome (H: hemolysis, EL: elevated liver enzymes and LP: low platelets) is a form of severe preeclampsia (PE). The syndrome can be: complete or incomplete (with three analytical criteria, or only one or two); Class i, ii or iii (according platelets < 50,000; 50,000-100,000 or > 100,000/mm3); postpartum or antepartum; with early or late installation (before or after the 34nd week of gestation). We describe and analyze characteristics and evolution observed in hypertensive pregnant patients who developed HELLP.
Material And Methods:
Retrospective cohort with observation period of two years. It included pregnant hypertensive women who developed HELLP, during the course of their hospitalization in the maternity hospital of our tertiary care hospital.
Results:
It included 318 hypertensive pregnant women. We observed 28 HELLP. Maternal age was 25.8 ±7.2 years and gestational age at diagnosis 31 ± 1 week. Hypertension was chronic in 4 and gestational in 24; eight had presented PE in the previous pregnancy. There were 10 complete and 18 incomplete syndromes; according to platelet disease there were 3 Class i, 16 Class ii and 9 Class iii. HELLP was postpartum in 3 and antepartum in 25: 18 early and 7 late. There were 17 patients who required intensive care and 10 developed complications linked to HELLP. No maternal deaths were recorded.
Conclusion:
Presentation was variable, exhibiting mostly in gestational hypertension, antepartum and early. Incomplete form and class II thrombocytopenia were more frequent. Maternal complications were frequent but no deaths were observed.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

